Activated protein C [drotrecogin-alfa] in acute stroke trial
Latest Information Update: 10 Nov 2021
At a glance
- Drugs Drotrecogin alfa (Primary)
- Indications Embolism and thrombosis; Stroke
- Focus Adverse reactions
- Acronyms APCAST
- 16 Dec 2010 Actual end date (Dec 2010) added as reported by ClinicalTrials.gov.
- 10 Dec 2010 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 11 Oct 2009 Planned end date (Aug 2011) added as reported by ClinicalTrials.gov.